IDYA logo

IDEAYA Biosciences (IDYA) EBIT

annual EBIT:

-$326.98M-$192.55M(-143.23%)
December 31, 2024

Summary

  • As of today (June 19, 2025), IDYA annual earnings before interest & taxes is -$326.98 million, with the most recent change of -$192.55 million (-143.23%) on December 31, 2024.
  • During the last 3 years, IDYA annual EBIT has fallen by -$276.71 million (-550.46%).
  • IDYA annual EBIT is now -2164.68% below its all-time high of -$14.44 million, reached on December 31, 2017.

Performance

IDYA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDYAincome statement metrics

quarterly EBIT:

-$84.39M+$59.75M(+41.45%)
March 31, 2025

Summary

  • As of today (June 19, 2025), IDYA quarterly earnings before interest & taxes is -$84.39 million, with the most recent change of +$59.75 million (+41.45%) on March 31, 2025.
  • Over the past year, IDYA quarterly EBIT has dropped by -$33.37 million (-65.41%).
  • IDYA quarterly EBIT is now -12886.21% below its all-time high of $660.00 thousand, reached on September 30, 2022.

Performance

IDYA quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDYAincome statement metrics

TTM EBIT:

-$360.35M-$33.37M(-10.21%)
March 31, 2025

Summary

  • As of today (June 19, 2025), IDYA TTM earnings before interest & taxes is -$360.35 million, with the most recent change of -$33.37 million (-10.21%) on March 31, 2025.
  • Over the past year, IDYA TTM EBIT has dropped by -$201.18 million (-126.39%).
  • IDYA TTM EBIT is now -5819.94% below its all-time high of -$6.09 million, reached on March 31, 2018.

Performance

IDYA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDYAincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

IDYA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-143.2%-65.4%-126.4%
3 y3 years-550.5%-493.4%-551.0%
5 y5 years-638.6%-576.3%-672.4%

IDYA EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-550.5%at low<-9999.0%+41.5%-562.1%at low
5 y5-year-825.1%at low<-9999.0%+41.5%-1082.9%at low
alltimeall time-2164.7%at low<-9999.0%+41.5%-5819.9%at low

IDYA EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$84.39M(-41.5%)
-$360.35M(+10.2%)
Dec 2024
-$326.98M(+143.2%)
-$144.14M(+115.5%)
-$326.98M(+45.5%)
Sep 2024
-
-$66.89M(+3.0%)
-$224.75M(+17.4%)
Jun 2024
-
-$64.93M(+27.3%)
-$191.39M(+20.2%)
Mar 2024
-
-$51.02M(+21.7%)
-$159.17M(+18.4%)
Dec 2023
-$134.43M(+115.1%)
-$41.92M(+25.0%)
-$134.43M(+13.0%)
Sep 2023
-
-$33.53M(+2.5%)
-$118.96M(+40.3%)
Jun 2023
-
-$32.71M(+24.5%)
-$84.77M(+13.7%)
Mar 2023
-
-$26.28M(-0.6%)
-$74.56M(+19.3%)
Dec 2022
-$62.50M(+24.3%)
-$26.44M(-4106.5%)
-$62.50M(+14.8%)
Sep 2022
-
$660.00K(-102.9%)
-$54.43M(-18.5%)
Jun 2022
-
-$22.50M(+58.2%)
-$66.80M(+20.7%)
Mar 2022
-
-$14.22M(-22.6%)
-$55.35M(+10.1%)
Dec 2021
-$50.27M
-$18.37M(+56.8%)
-$50.27M(+35.2%)
Sep 2021
-
-$11.71M(+6.0%)
-$37.18M(+22.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$11.05M(+21.0%)
-$30.46M(-4.8%)
Mar 2021
-
-$9.13M(+73.0%)
-$32.00M(-9.5%)
Dec 2020
-$35.34M(-20.2%)
-$5.28M(+5.7%)
-$35.34M(-14.6%)
Sep 2020
-
-$5.00M(-60.3%)
-$41.38M(-13.8%)
Jun 2020
-
-$12.59M(+0.9%)
-$48.01M(+2.9%)
Mar 2020
-
-$12.48M(+10.2%)
-$46.66M(+5.4%)
Dec 2019
-$44.27M(+21.6%)
-$11.32M(-2.6%)
-$44.27M(+5.2%)
Sep 2019
-
-$11.62M(+3.5%)
-$42.09M(-4.5%)
Jun 2019
-
-$11.23M(+11.3%)
-$44.09M(+9.1%)
Mar 2019
-
-$10.09M(+10.5%)
-$40.42M(+11.0%)
Dec 2018
-$36.42M(+152.2%)
-$9.13M(-33.0%)
-$36.42M(+33.5%)
Sep 2018
-
-$13.63M(+80.0%)
-$27.28M(+99.8%)
Jun 2018
-
-$7.57M(+24.4%)
-$13.66M(+124.4%)
Mar 2018
-
-$6.09M
-$6.09M
Dec 2017
-$14.44M
-
-

FAQ

  • What is IDEAYA Biosciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for IDEAYA Biosciences?
  • What is IDEAYA Biosciences annual EBIT year-on-year change?
  • What is IDEAYA Biosciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for IDEAYA Biosciences?
  • What is IDEAYA Biosciences quarterly EBIT year-on-year change?
  • What is IDEAYA Biosciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for IDEAYA Biosciences?
  • What is IDEAYA Biosciences TTM EBIT year-on-year change?

What is IDEAYA Biosciences annual earnings before interest & taxes?

The current annual EBIT of IDYA is -$326.98M

What is the all time high annual EBIT for IDEAYA Biosciences?

IDEAYA Biosciences all-time high annual earnings before interest & taxes is -$14.44M

What is IDEAYA Biosciences annual EBIT year-on-year change?

Over the past year, IDYA annual earnings before interest & taxes has changed by -$192.55M (-143.23%)

What is IDEAYA Biosciences quarterly earnings before interest & taxes?

The current quarterly EBIT of IDYA is -$84.39M

What is the all time high quarterly EBIT for IDEAYA Biosciences?

IDEAYA Biosciences all-time high quarterly earnings before interest & taxes is $660.00K

What is IDEAYA Biosciences quarterly EBIT year-on-year change?

Over the past year, IDYA quarterly earnings before interest & taxes has changed by -$33.37M (-65.41%)

What is IDEAYA Biosciences TTM earnings before interest & taxes?

The current TTM EBIT of IDYA is -$360.35M

What is the all time high TTM EBIT for IDEAYA Biosciences?

IDEAYA Biosciences all-time high TTM earnings before interest & taxes is -$6.09M

What is IDEAYA Biosciences TTM EBIT year-on-year change?

Over the past year, IDYA TTM earnings before interest & taxes has changed by -$201.18M (-126.39%)
On this page